Thousands of general practices to receive COVID vaccine doses within weeks A change in strategy will see all 4600 participating practices added to the rollout over four weeks, allowing more patients to be vaccinated by their own GP.
How will GPs tackle COVID vaccine hesitancy? Events like this week’s abandoned University of Queensland trial are unlikely to inspire confidence in people with questions about the safety of a COVID vaccine.
Peer-reviewed AstraZeneca data raises questions over vaccine rollout Publication of the highly anticipated data has highlighted the need for further trials to confirm dosage and efficacy.
What does a new Oxford COVID vaccine trial mean for Australia? The decision comes after doubts emerged over recent trial results that showed greater efficacy with a lower dosage.
The Oxford deal is welcome – but the vaccine is still being trialled The Federal Government’s deal is contingent on the current phase 3 trials being successful.
Australian researchers developing single vaccine for flu and pneumonia As Australia remains in the grip of a severe flu season, a new vaccine may be able to take on two deadly respiratory diseases at once.
Keeping up with cancer care The Chair of the RACGP Breast Medicine Specific Interests network is working hard to stay up to date with a rapidly advancing field.
World-first guideline for work-related mental health conditions People experiencing work-related mental health issues take up to three times longer to return to work than those with physical injuries.
Commercial sensitivity or patient protection? Secrecy and medicine safety Researchers have identified an information gap between pharmacological companies and Australian clinicians on the potential safety risks of medicines.
Undisclosed pharmaceutical payments ‘a cause for concern’ A drop in disclosures related to pharmaceutical company payments to the Australian healthcare sector has prompted calls for more transparency.